• · Sep. 2016 – present: Director,
•   Department of Psychiatry,
•   Korea University Medical Center Ansan Hospitals, Seoul, Korea.
• · Oct. 2015 – Present: Director,
•   Ansan Mental Health Trauma Centre
• · Reviewer for Journal of Clinical Psychopharmacology, Clinical Psychopharmacology and Neuroscience,
•   Psychiatry Investigation, Journal of Korean Neuropsychiatric Association (Korean), Korean Journal of
•   Psychopharmacology (Korean), and Korean Journal of Psychosomatic Medicine (Korean).
• · Member:
•   Korean Neuropsychiatric Association,
•   The Korean Society of Biological Psychiatry,
•   The Korean Society of Psychopharmacology,
•   The Korean Society of Geriatric Psychiatry,
•   The Korean Academy of Addiction Psychiatry,
•   The Korean Society of Human Brain Mapping,
•   The Korean Psychosomatic Society,
•   The World Federation of Societies of Biological Psychiatry,
•   The European Association of Psychosomatic Association.

Education

• · 1995: M.D., Korea University College of Medicine, Seoul, Korea.
• · 2005: Ph.D., Korea University Postgraduate School, Seoul, Korea.
• · May 1995 – Feb. 1996: Rotating Internship,
•   Korea University Medical Center Guro Hospital, Seoul, Korea.
• · Mar. 1996 – Feb. 2000: Psychiatry Resident,
•   Department of Psychiatry, Korea University Medical Center Guro Hospital, Seoul, Korea.

Professional Experiences

• · Mar. 2000 - May 2003: Physician in ROK Army (rank: captain grade),
•   Full-time faculty, General teaching and supervisory duties,
•   Department of Psychiatry,
•   National Bugok Hospital, Gyeongsangnam-Do, Korea.
• · May 2003 – Aug. 2006: Clinical Assistant Professor,
•   Department of Psychiatry,
•   Korea University Medical Center Guro & Ansan Hospitals, Seoul, Korea.
• · Sep. 2006 – Feb. 2009: Assistant Professor,
•   Mar. 2009 – Feb. 2014: Associate Professor,
•   Mar. 2014 – present: Professor,
•   Department of Psychiatry,
•   Korea University College of Medicine, Seoul, Korea.
• · Mar. 2013 – Feb. 2014: Visiting scholar,
•   Swartz Center for Computational Neuroscience, Institute for Neural Computation
•   University of California San Diego, La Jolla CA
• · Chief Editor, Korean Journal of Psychosomatic Medicine, Mar. 2008 – Feb. 2013.
• · Director of Ansan Community Mental Health Center, Mar. 2010 – Feb. 2013.
• · Director of Ansan Community Mental Health Center, Mar. 2014 – Oct. 2015.
• · Director of Ansan Alcoholic Counseling Center, Mar. 2010 – Feb. 2013.
• · Licensed to Practice Medicine in Korea, 1995.
• · Korean Board of Psychiatry, 2000.

International Journal

• 1) Kim YK, Kim SH, Choi SH, Ko YH, Kim L, Lee MS, Suh KY, Kwak DI, Song KJ, Lee YJ, Yanagihara R, Song JW: Failure to Demonstrate Borna Disease Virus Genome in Peripheral Blood Mononuclear Cells from Psychiatric Patients in Korea. Journal of Neurovirology 5:196-199, 1999.
• 2) Ko YH, Joe SH, Jung IK, Kim SH: Topiramate as an adjuvant treatment with atypical antipsychotics in schizophrenic patients experiencing weight gain. Clinical Neuropharmacology 28(4):169-175, 2005.
• 3) Ko YH, Joe SH, Cho W, Park JH, Lee JJ, Jung IK, Kim L, Kim SH: Effect of hormone replacement therapy on cognitive function in women with chronic schizophrenia. International Journal of Psychiatry in Clinical Practice 10(2):97-104, 2006.
• 4) Lee MS, Ko YH, Lee SH, Seo YJ, Kim SH, Joe SH, Han CS, Lee JH, Jung IK: Long-term treatment with long-acting risperidone in Korean patients with schizophrenia. Human Psychopharmacology and Clinical Experience 21:399–407, 2006.
• 5) Ko YH, Joe SH, Cho W, Park JH, Lee JJ, Jung IK, Kim L, Kim SH: Estrogen, cognitive function and negative symptoms in female schizophrenia. Neuropsychobiology 53:169–175, 2006.
• 6) Ko YH, Jung SW, Joe SH, Lee CH, Jung HG, Jung IK, Kim SH, Lee MS. Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia. Psychoneuroendocrinology 32:385–391, 2007.
• 7) Lee MS, Ko YH, Song HS, Kwon KH, Lee HS, Nam M, Jung IK. Characteristics of Internet use in relation to game genre in Korean adolescents. CYBERPSYCHOLOGY & BEHAVIOR 10(2):278-285,2007.
• 8) Han CS, Lee MS, Pae CU, Ko YH, Patkar AA, Jung IK. Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry 31:1219–1223, 2007.
• 9) Han CS, Pae CU, Lee BH, Ko YH, Masand PS, Patkar AA, Jung IK: Fluoxetine versus sertraline in the treatment of patients with undifferentiated somatoform disorder: A randomized, open-label, 12-week, parallel-group trial. Progress in Neuro-Psychopharmacology & Biological Psychiatry 32:437–444, 2008.
• 10) Lee MS, Yang JW, Ko YH, Han CS, Kim SH, Lee MS, Joe SH, Jung IK: Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder. Child Psychiatry and Human Development 39:201–209, 2008.
• 11) Ko YH, Lew YM, Jung SW, Joe SH, Lee CH, Jung HG, Lee MS. Short-term testosterone augmentation in male schizophrenics - A randomized, double-blind, placebo-controlled trial. Journal of Clinical Psychopharmacology 28:375–383, 2008.
• 12) Han CS, Pae CU, Lee BH, Ko YH, Masand PS, Patkar AA, Joe SH, Jung IK. Venlafaxine versus mirtazapine in the treatment of undifferentiated somatoform disorder - A 12-week prospective, open-label, randomized, parallel-group trial. Clinical Drug Investigation 28(4):251-261, 2008.
• 13) Kim YK, Lee AR, Hur JW, Yoon HK, Lee BH, Ko YH. Cognitive Factors for Predicting Treatment Response in Schizophrenic Patients: One-Year Follow-Up Study. Psychiatry Investigation 5:106-114, 2008.
• 14) Kim JH, Kim JW, Ko YH, Choi CU, Na JO, Kim EJ, Rha SW, Park CG, Seo HS, Oh DJ. Coronary endothelial dysfunction associated with a depressive mood in patients with atypical angina but angiographically normal coronary artery. International Journal of Cardiology 2010;143(2):154-157.
• 15) Lee MS, Kim JH, Park MS, Yang JW, Ko YH, Ko SD, Joe SH. Factors Influencing the Severity of Menopause Symptoms in Korean Post-menopausal Women. J Korean Med Sci 2010;25: 758-65.
• 16) Lim HE, Lee MS, Ko YH, Park YM, Joe SH, Kim YK, Han C, Lee HY, Pedersen SS, Denollet J. Assessment of the Type D Personality Construct in the Korean Population: A Validation Study of the Korean DS14. J Korean Med Sci 2011;26:116-123.
• 17) Lim JH, Ko YH, Joe SH, Han C, Lee MS, Yang JW. Zonisamide produces weight loss in psychotropic drug-treated psychiatric outpatients. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011;35(8):1918-1921.
• 18) Yang JW, Joe SH, Lee MS, Ko YH, Jung IK, Kim SH. Effects of Long-Term Combination Treatment with Valproate and Atypical Antipsychotics on Bone Mineral Density and Bone Metabolism in Premenopausal Patients with Bipolar Disorder: A Preliminary Study. Psychiatry Investig 2011;8(3):256–261.
• 19) Yang JW, Ko YH, Paik JW, Lee MS, Han C, Joe SH, Jung IK, Jung HG, Kim SH. Symptom severity and attitudes toward medication: Impacts on adherence in outpatients with schizophrenia. Schizophr Res. 2012;134(2-3):226-31.
• 20) Shin C, Han C, Linden M, Chae JH, Ko YH, Kim YK, Kim SH, Joe SH, Jung IK. Standardization of the Korean version of the posttraumatic embitterment disorder self-rating scale. Psychiatry Investig. 2012;9(4):368-72.
• 21) Na KS, Oh SJ, Jung HY, Lee SI, Kim YK, Han C, Ko YH, Paik JW, Kim SG. Temperament and character of young male conscripts with adjustment disorder: a case-control study. J Nerv Ment Dis. 2012;200(11):973-7.
• 22) Jeong HG, Lee MS, Lee HY, Ko YH, Han C, Joe SH. Changes in sexual function and gonadal axis hormones after switching to aripiprazole in male schizophrenia patients: a prospective pilot study. Int Clin Psychopharmacol. 2012;27(4):177-83.
• 23) Jeong HG, Lee MS, Ko YH, Han C, Jung IK. Combination treatment with aripiprazole and valproic acid for acute mania: an 8-week, single-blind, randomized controlled trial. Clin Neuropharmacol. 2012;35(3):97-102
• 24) Lee MS, Lim HE, Ko YH, Han C, Kim YK, Yang J, Kim JJ, Lee JE, Cha JY, Lee H. Characteristics of Type D personality in Korean adolescents. Eur Child Adolesc Psychiatry. 2012;21(12):699-706.
• 25) Kim YH, Kim SH, Lim SY, Cho GY, Baik IK, Lim HE, Na JO, Han SW, Ko YH, Shin C. Relationship between depression and subclinical left ventricular changes in the general population. Heart. 2012;98(18):1378-83.
• 26) Yang J, Choi W, Ko YH, Joe SH, Han C, Kim YK. Bright light therapy as an adjunctive treatment with risperidone in patients with delirium: a randomized, open, parallel group study. Gen Hosp Psychiatry. 2012;34(5):546-51.
• 27) Na KS, Oh SJ, Jung HY, Irene Lee S, Kim YK, Han C, Ko YH, Paik JW, Kim SG. Alexithymia and low cooperativeness are associated with suicide attempts in male military personnel with adjustment disorder: a case-control study. Psychiatry Res. 2013;205(3):220-6.
• 28) Jeong HG, Ko YH, Han C, Kim YK, Joe SH. Distinguishing Quantitative Electroencephalogram Findings between Adjustment Disorder and Major Depressive Disorder. Psychiatry Investig. 2013;10(1):62-8.
• 29) Kim JW, Kim YK, Hwang JA, Yoon HK, Ko YH, Han C, Lee HJ, Ham BJ, Lee HS. Plasma Levels of IL-23 and IL-17 before and after Antidepressant Treatment in Patients with Major Depressive Disorder. Psychiatry Investig. 2013;10:294-299.
• 30) Lim HE, Lee MS, Ko YH, Park YM, Han C, Joe SH. Distressed personality without a partner enhances the risk of depression in patients with coronary heart disease. Asia Pac Psychiatry. 2013 Dec;5(4):284-92. doi: 10.1111/appy.12016.
• 31) Won E, Park SC, Han KM, Sung SH, Lee HY, Paik JW, Jeon HJ, Lee MS, Shim SH, Ko YH, Lee KJ, Han C, Ham BJ, Choi J, Hwang TY, Oh KS, Hahn SW, Park YC, Lee MS. Evidence-Based, Pharmacological Treatment Guideline for Depression in Korea, Revised Edition. J Korean Med Sci. 2014 Apr;29(4):468-84.
• 32) Kim YK, Hwang JA, Lee HJ, Yoon HK, Ko YH, Lee BH, Jung HY, Hahn SW, Na KS. Association between norepinephrine transporter gene (SLC6A2) polymorphisms and suicide in patients with major depressive disorder. J Affect Disord. 2014 Apr;158:127-32.
• 33) Park YM, Ko YH, Lee MS, Lee HJ, Kim L. Type-D Personality Can Predict Suicidality in Patients with Major Depressive Disorder. Psychiatry Investig. 2014 Jul;11(3):232-6.
• 34) Ko YH, Na KS, Kim CE, Kim SH, Jeon YW, Yi JS, Lee MS, Kim SG, Jeong HG, Jung HY. The Effectiveness of Cross-Tapering Switching to Ziprasidone in Patients with Schizophrenia or Schizoaffective Disorder. Psychiatry Investig. 2014 Oct;11(4):459-66.
• 35) Jeong HG, Ko YH, Oh SY, Han C, Kim T, Joe SH. Effect of Korean Red Ginseng as an adjuvant treatment for women with residual symptoms of major depression. Asia Pac Psychiatry. 2015 Sep;7(3):330-6. doi: 10.1111/appy.12169. Epub 2014 Dec 12.
• 36) Jeong HG, Ko YH, Han C, Oh SY, Park KW, Kim T, Ko D. The impact of 3D and 2D TV watching on neurophysiological responses and cognitive functioning in adults. Eur J Public Health. 2015 Dec;25(6):1047-52.
• 37) Jeon SW, Han C, Lee J, Lim J, Jeong HG, Park MH, Ko YH, Pae CU, Kim SH, Joe SH, Steffens DC. Perspectives on the Happiness of Community-Dwelling Elderly in Korea. Psychiatry Investig. 2016 Jan;13(1):50-7.
• 38) Jeon SW, Yoon HK., Han C, Ko YH. Kim YK Won YJ. Second-to-fourth digit length ratio as a measure of harm avoidance. Personality and Individual Differences, 2016;97:30-34. DOI: 10.1016/j.paid.2016.03.017
• 39) Jeon SW, Yoon SY, Ko YH, Joe SH, Kim YK, Han C, Yoon HK, Liu CY. Do Somatic Symptoms Predict the Severity of Depression? A Validation Study of the Korean Version of the Depression and Somatic Symptoms Scale. J Korean Med Sci. 2016 Dec;31(12):2002-2009. doi: 10.3346/jkms.2016.31.12.2002.
• 40) Yoon S, Jeon SW, Ko YH, Patkar AA, Masand PS, Pae CU, Han C. Adjunctive Brexpiprazole as a Novel Effective Strategy for Treating Major Depressive Disorder: A Systematic Review and Meta-Analysis. J Clin Psychopharmacol. 2017 Feb;37(1):46-53.
• 41) Jeon SW, Han C, Ko YH, Yoon SY, Pae CU, Choi J, Park YC, Kim JW, Yoon HK, Ko SD, Patkar AA, Zimmerman M. Measurement-based Treatment of Residual Symptoms Using Clinically Useful Depression Outcome Scale: Korean Validation Study. Clin Psychopharmacol Neurosci. 2017 Feb 28;15(1):28-34. doi: 10.9758/cpn.2017.15.1.28.
• 42) Park JH, Cho H, Kim JY, Song JH, Moon S, Cha SH, Choi BM, Han CS, Ko YH, Lee H. The Sewol Ferry Disaster: Experiences of a Community-Based Hospital in Ansan City. Disaster Med Public Health Prep. 2017 Jun;11(3):389-393. doi: 10.1017/dmp.2016.134.
• 43) Shin C, Kim Y, Park S, Yoon S, Ko YH, Kim YK, Kim SH, Jeon SW, Han C. Prevalence and Associated Factors of Depression in General Population of Korea: Results from the Korea National Health and Nutrition Examination Survey, 2014. J Korean Med Sci. 2017 Nov;32(11):1861-1869. doi: 10.3346/jkms.2017.32.11.1861.
• 44) Han KM, Han C, Shin C, Jee HJ, An H, Yoon HK, Ko YH, Kim SH. Social capital, socioeconomic status, and depression in community-living elderly. J Psychiatr Res. 2018 Mar;98:133-140. doi: 10.1016/j.jpsychires.2018.01.002.
• 45) Han KM, Ko YH, Shin C, Lee JH, Choi J, Kwon DY, Yoon HK, Han C, Kim YK. Tinnitus, depression, and suicidal ideation in adults: A nationally representative general population sample. J Psychiatr Res. 2018 Mar;98:124-132.
• 46) Park SA, Jeon SW, Yoon HK, Yoon SY, Shin C, Ko YH. Characteristics of Residual Symptoms in Korean Patients with Major Depressive Disorder: A Validation Study for the Korean Version of Depression Residual Symptom Scale. Psychiatry Investig. 2018 Feb;15(2):178-185.

Research Topic

Neuropsychophysiological diagnosis and treatment of psychiatric and psychosomatic disorders.

• Psychosomatic medicine.
• Consultation liaison psychiatry